Skip to main content
Home
About Us
About Compugen
Leadership
Board of Directors
Scientific and Strategic Advisory Board
Contact Us
Our Science
Unigen™
Pipeline
Clinical Trials
Publications
Investors and Media
Overview
Press Releases
Events
Stock Information
NASDAQ: CGEN
TASE: CGEN.TA
Analyst Coverage
Financials
Quarterly Results, Annual Reports and Proxy
SEC Filings
Media
Governance
Governance Documents
Leadership
Committee Composition
Investor Contacts
Investor FAQs
Corporate Presentation
Collaborations
Careers
Follow Us
LinkedIn
X
Email Alerts
News Details
View All News
ILDR2-Fc is a Novel Regulator of Immune Homeostasis and Inducer of Antigen- Specific Immune Tolerance
February 5, 2018
Research
(opens in new window)
View All News